Skip to main content
eScholarship
Open Access Publications from the University of California

Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma

  • Author(s): Hashizume, R
  • Andor, N
  • Ihara, Y
  • Lerner, R
  • Gan, H
  • Chen, X
  • Fang, D
  • Huang, X
  • Tom, MW
  • Ngo, V
  • Solomon, D
  • Mueller, S
  • Paris, PL
  • Zhang, Z
  • Petritsch, C
  • Gupta, N
  • Waldman, TA
  • James, CD
  • et al.

Published Web Location

https://doi.org/10.1038/nm.3716
Abstract

© 2014 Nature America, Inc. All rights reserved. Pediatric brainstem gliomas often harbor oncogenic K27M mutation of histone H3.3. Here we show that GSKJ4 pharmacologic inhibition of K27 demethylase JMJD3 increases cellular H3K27 methylation in K27M tumor cells and demonstrate potent antitumor activity both in vitro against K27M cells and in vivo against K27M xenografts. Our results demonstrate that increasing H3K27 methylation by inhibiting K27 demethylase is a valid therapeutic strategy for treating K27M-expressing brainstem glioma.

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Main Content
Current View